Showing results (11-20 of 212) with videos related to
Sort By:
Pageof 22
Methods in Molecular Biology (Clifton, N.J.)|September 15, 2010
Quantification of proteins by label-free LC-MS/MSYishai Levin, Sabine BahnExpert Review of Molecular Diagnostics|March 28, 2008
Cerebrospinal fluid: identification of diagnostic markers for schizophreniaEmanuel Schwarz, Sabine BahnScientific Reports|October 5, 2017
Associations between SNPs and immune-related circulating proteins in schizophreniaMan K Chan, Jason D Cooper, Stefanie Heilmann-Heimbach, et al.ACS Chemical Neuroscience|June 27, 2018
Clinical Trials and Therapeutic Rationale for Drug Repurposing in SchizophreniaSantiago G Lago, Sabine BahnNPJ Genomic Medicine|March 26, 2022
The druggable schizophrenia genome: from repurposing opportunities to unexplored drug targetsSantiago G Lago, Sabine BahnThe International Journal of Neuropsychopharmacology|June 6, 2014
Proteomic changes in serum of first onset, antidepressant drug-naïve major depression patientsViktoria Stelzhammer, Frieder Haenisch, Man K Chan, et al.Molecular Autism|August 5, 2017
A brain proteomic investigation of rapamycin effects in the Tsc1+/- mouse modelHendrik Wesseling, Ype Elgersma, Sabine BahnBiomarkers in Medicine|May 19, 2010
Problems and promise of immunological factors as biomarkers for schizophreniaM Herberth, E Schwarz, Sabine BahnProteomics|July 14, 2011
Quantification of proteins using data-independent analysis (MSE) in simple andcomplex samples: a systematic evaluationYishai Levin, Eva Hradetzky, Sabine BahnJournal of Psychiatric Research|October 4, 2016
Blood-based immune-endocrine biomarkers of treatment response in depressionMan K Chan, Jason D Cooper, Mariska Bot, et al.Pageof 22